These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 28087282)
1. Short-term perioperative teriparatide therapy for the prevention of medication-related osteonecrosis of the jaw: A randomized, controlled preclinical study in rats. Zandi M; Dehghan A; Mohammadi-Mofrad A; Amini P; Vahdatinia F J Craniomaxillofac Surg; 2017 Feb; 45(2):275-280. PubMed ID: 28087282 [TBL] [Abstract][Full Text] [Related]
2. Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study. Keskinruzgar A; Bozdag Z; Aras MH; Demir T; Yolcu U; Cetiner S J Oral Maxillofac Surg; 2016 Jan; 74(1):68-78. PubMed ID: 26215490 [TBL] [Abstract][Full Text] [Related]
3. Effect of different doses and durations of teriparatide therapy on resolution of medication-related osteonecrosis of the jaw: A randomized, controlled preclinical study in rats. Zandi M; Dehghan A; Zandipoor N; Amini P; Doulati S J Craniomaxillofac Surg; 2018 Mar; 46(3):466-472. PubMed ID: 29395991 [TBL] [Abstract][Full Text] [Related]
4. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model. Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800 [TBL] [Abstract][Full Text] [Related]
5. Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats. Zandi M; Dehghan A; Ghadermazi K; Malekzadeh H; Akbarzadeh M J Craniomaxillofac Surg; 2015 Nov; 43(9):1823-8. PubMed ID: 26355024 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effect of teriparatide therapy on mandibular fracture healing in rats with medication-related osteonecrosis of the jaw. Zandi M; Dehghan A; Amini P; Doulati S; Rezaeian L Clin Oral Investig; 2019 Nov; 23(11):3987-3993. PubMed ID: 30715621 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Osteonecrosis of the Jaw. Yamachika E; Matsubara M; Ikeda A; Matsumura T; Moritani N; Iida S J Craniofac Surg; 2015 Oct; 26(7):e575-7. PubMed ID: 26468825 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Methenolone Enanthate Efficacy in Preventing MRONJ: A Randomized Trial on Rats. Gürses G; Sur E; Cengiz ZO; Körez MK J Oral Pathol Med; 2024 Sep; 53(8):530-537. PubMed ID: 39113433 [TBL] [Abstract][Full Text] [Related]
9. Further development of the MRONJ minipig large animal model. Otto S; Pautke C; Martin Jurado O; Nehrbass D; Stoddart MJ; Ehrenfeld M; Zeiter S J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745 [TBL] [Abstract][Full Text] [Related]
10. Management of medication-related osteonecrosis of jaw: Comparison between icariin and teriparatide in a rat model. Liu J; Mattheos N; Deng C; Su C; Wang Z; Luo N; Tang H J Periodontol; 2021 Jan; 92(1):149-158. PubMed ID: 32281098 [TBL] [Abstract][Full Text] [Related]
11. Effect of pentoxifylline and α-tocopherol on medication-related osteonecrosis of the jaw in rats: Before and after dental extraction. Delfrate G; Mroczek T; Mecca LEA; Andreis JD; Fernandes D; Lipinski LC; Claudino M; Franco GCN Arch Oral Biol; 2022 May; 137():105397. PubMed ID: 35286947 [TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats. Barba-Recreo P; Del Castillo Pardo de Vera JL; García-Arranz M; Yébenes L; Burgueño M J Craniomaxillofac Surg; 2014 Sep; 42(6):744-50. PubMed ID: 24342733 [TBL] [Abstract][Full Text] [Related]
13. In vivo effects of geranylgeraniol on the development of bisphosphonate-related osteonecrosis of the jaws. Koneski F; Popovic-Monevska D; Gjorgoski I; Krajoska J; Popovska M; Muratovska I; Velickovski B; Petrushevska G; Popovski V J Craniomaxillofac Surg; 2018 Feb; 46(2):230-236. PubMed ID: 29233701 [TBL] [Abstract][Full Text] [Related]
14. Animal model for medication-related osteonecrosis of the jaw with precedent metabolic bone disease. Kim JW; Tatad JCI; Landayan MEA; Kim SJ; Kim MR Bone; 2015 Dec; 81():442-448. PubMed ID: 26297440 [TBL] [Abstract][Full Text] [Related]
15. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? Hasegawa T; Kawakita A; Ueda N; Funahara R; Tachibana A; Kobayashi M; Kondou E; Takeda D; Kojima Y; Sato S; Yanamoto S; Komatsubara H; Umeda M; Kirita T; Kurita H; Shibuya Y; Komori T; Osteoporos Int; 2017 Aug; 28(8):2465-2473. PubMed ID: 28451732 [TBL] [Abstract][Full Text] [Related]
16. Zoledronate induces osteonecrosis of the jaw in sheep. Voss PJ; Stoddart M; Ziebart T; Zeiter S; Nelson K; Bittermann G; Schmelzeisen R; Poxleitner P J Craniomaxillofac Surg; 2015 Sep; 43(7):1133-8. PubMed ID: 26154396 [TBL] [Abstract][Full Text] [Related]
17. Influence of induced infection in medication-related osteonecrosis of the jaw development after tooth extraction: A study in rats. Bolette A; Lecloux G; Rompen E; Albert A; Kerckhofs G; Lambert F J Craniomaxillofac Surg; 2019 Feb; 47(2):349-356. PubMed ID: 30595476 [TBL] [Abstract][Full Text] [Related]